Literature DB >> 6233370

Inhibition of T cell responses to alloantigens and polyclonal mitogens by Ly-5 antisera.

J A Harp, B S Davis, S J Ewald.   

Abstract

The effects of Ly-5 alloantisera on the generation of cytotoxic T cells (CTL), on the effector phase of CTL killing, and on polyclonal mitogenesis were studied. Ly-5 antisera added at the beginning of mixed lymphocyte culture (MLC) suppressed the production of CTL in an allele-specific manner. Neither Ly-5.1 nor Ly-5.2 antisera inhibited the generation of cytotoxic effectors by Ly-5.1/Ly-5.2 heterozygous spleen cells; however, a combination of Ly-5.1 and Ly-5.2 antisera markedly suppressed the appearance of Ly-5 heterozygous CTL. Similarly, Ly-5 antisera inhibited the effector phase of CTL killing in an allele-specific manner. In addition, Ly-5 alloantisera specifically blocked concanavalin A and oxidative mitogenesis of splenocytes carrying the appropriate Ly-5 alloantigen. The results are discussed in light of a possible functional role of Ly-5 molecules in immune processes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233370

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Anti-leucocyte common (CD45) antibodies inhibit dendritic cell stimulation of CD4 and CD8 T-lymphocyte proliferation.

Authors:  T C Prickett; D N Hart
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

2.  Effects of Ly-5 antibodies on antibody-dependent cell-mediated cytotoxicity (ADCC).

Authors:  R M Small; S M Walden; S J Ewald
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

3.  Further data on the selective expression of Ly-5 isoforms.

Authors:  Y Saga; K Furukawa; P Rogers; J S Tung; D Parker; E A Boyse
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

4.  Expression of the T200 family of glycoproteins in canine malignant lymphoma.

Authors:  U M Sarmiento; V E Valli
Journal:  Can J Vet Res       Date:  1987-01       Impact factor: 1.310

5.  The monoclonal antibody, UCHL1, recognizes a 180,000 MW component of the human leucocyte-common antigen, CD45.

Authors:  L A Terry; M H Brown; P C Beverley
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

6.  Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16.

Authors:  A Pallant; A Eskenazi; M G Mattei; R E Fournier; S R Carlsson; M Fukuda; J G Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

7.  CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells.

Authors:  J A Ledbetter; N K Tonks; E H Fischer; E A Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Effect of Ly 5 allotype on in vitro immune responses.

Authors:  R E Taffs; S J Ewald
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

9.  Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens.

Authors:  L Lefrancois; L Puddington; C E Machamer; M J Bevan
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

10.  Regulatory role of OX22high T cells in mercury-induced autoimmunity in the brown Norway rat.

Authors:  P W Mathieson; S Thiru; D B Oliveira
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.